Lightbulb Moment

Tevogen’s groundbreaking work in targeted T-cell therapies is rooted in two fundamental beliefs. First, the next frontier of medical innovation lies in the purposeful development of accessible, personalized immunotherapies. Second, we must look to disruptive business models to sustain medical innovation in a post-pandemic reality.

Renting office space in CIC Warsaw gives EcoBean access to a collaborative community of fellow researchers and innovators who are all working toward a shared goal: innovation designed to make meaningful progress to tackle climate change.